Innophos Holdings, Inc., Cranbury, NJ, an international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets, has completed the acquisition of the business and assets of Triarco Industries, Inc.
 
Triarco, a privately held company based in Wayne, NJ, manufactures custom ingredients for the food, beverage, dietary supplement and nutraceutical industries, specializing in botanical and enzyme based ingredients. Triarco is highly complementary to the mineral ingredients businesses, Kelatron and AMT, which were acquired by Innophos in 2011 and 2012. Triarco has annualized revenues of approximately $25 million and margins in line with those earned by Innophos’ existing specialty ingredients businesses. The combined businesses of Kelatron, AMT and Triarco enhance Innophos’ position in the attractive high growth nutritional ingredients end markets with annual revenues in excess of $50 million.
 
In the transaction, an Innophos subsidiary purchased all of Triarco’s assets for $45 million in cash plus $1 million in shares of Innophos Holdings, Inc. Common Stock. The cash portion of the purchase price was financed by Innophos from borrowings under the company’s senior credit facility. The acquisition includes potential for additional incentive consideration contingent upon success in delivering growth objectives over the next two years. Closing of the purchase occurred upon execution of the definitive agreements effective as of December 31, 2012.  The acquisition is expected to be accretive to earnings per share in 2013.